Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tran, Thanh Huyen ^a   Rastogi, Ruchir ^a   Shelke, Juili ^a   Amiji, Mansoor M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 10; INTERLEUKIN 4; NANOPARTICLE;

ANIMAL; C57BL MOUSE; CHEMISTRY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; PHENOTYPE; PLASMID;

ANIMALS; ANTIGENS, CD44; CYTOKINES; GENE EXPRESSION; HYALURONIC ACID; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NANOPARTICLES; PHENOTYPE; PLASMIDS; TRANSFECTION;

EID: 84947483916     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16632     Document Type: Article

References (38)

1. Fujiwara, N., Kobayashi, K. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy 4, 281-286 (2005).
2. Heinsbroek, S. E., Gordon, S. The role of macrophages in inflammatory bowel diseases. Expert Rev. Mol. Med. 11, e14 (2009).
3. Tran, T. H., Amiji, M. M. Targeted delivery systems for biological therapies of inflammatory diseases. Expert Opin Drug Deliv, 1-22 (2014).
4. Brown, B. N., Valentin, J. E., Stewart-Akers, A. M., McCabe, G. P., Badylak, S. F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30, 1482-1491 (2009).
5. Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686 (2004).
6. Shi, C., Pamer, E. G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762-774 (2011).
7. Ghosn, E. E. et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc. Natl. Acad. Sci. USA 107, 2568-2573 (2010).
8. Lameire, N. et al. Experimental models in peritoneal dialysis: a European experience. Kidney Int. 54, 2194-2206 (1998).
9. Shrivastava, P., Bhatia, M. Essential role of monocytes and macrophages in the progression of acute pancreatitis. World J. Gastroenterol. 16, 3995-4002 (2010).
10. Nawroth, I. et al. Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model. Acta Oncol. 52, 1730-1738 (2013).
11. Howard, K. A. et al. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for antiinflammatory treatment in a murine arthritis model. Mol Ther. 17, 162-168 (2009).
12. Fellowes, R. et al. Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. Gene Ther. 7, 967-977 (2000).
13. Novak, M. L., Koh, T. J. Macrophage phenotypes during tissue repair. J. Leukoc. Biol. 93, 875-881 (2013).
14. Lu, J. et al. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int. 84, 745-755 (2013).
15. Martinez, F. O., Sica, A., Mantovani, A., Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453-461 (2008).
16. Bonadio, J., Smiley, E., Patil, P., Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753-759 (1999).
17. Ganesh, S., Iyer, A. K., Morrissey, D. V., Amiji, M. M. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors. Biomaterials 34, 3489-3502 (2013).
18. Ganesh, S., Iyer, A. K., Gattacceca, F., Morrissey, D. V., Amiji, M. M. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles. J. Control. Release 172, 699-706 (2013).
19. Han, H. S. et al. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo. J. Control. Release 168, 105-114 (2013).
20. He, Y. et al. Polyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery. Biomaterials 34, 1235-1245 (2013).
21. Glucksam-Galnoy, Y., Zor, T., Margalit, R. Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response. J. Control. Release 160, 388-393 (2012).
22. Fernandes Stefanello, T. et al. Thermoresponsive hyaluronic acid nanogels as hydrophobic drug carrier to macrophages. Acta Biomater 10, 4750-4758 (2014).
23. Yu, H. et al. Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS Nano 5, 9246-9255 (2011).
24. Yang, X. et al. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer. Pharm. Res. doi: 10.1007/s11095-014-1602-1 (2014).
25. Edin, S. et al. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 7, e47045 (2012).
26. Inoue, T., Plieth, D., Venkov, C. D., Xu, C., Neilson, E. G. Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int. 67, 2488-2493 (2005).
27. Yu, S. S. et al. Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles. Mol. Pharm. 10, 975-987 (2013).
28. Vigerust, D. J., Vick, S., Shepherd, V. L. Characterization of functional mannose receptor in a continuous hybridoma cell line. BMC Immunol. 13, 51 (2012).
29. Zhang, Q., Chen, S., Zhuo, R. X., Zhang, X. Z., Cheng, S. X. Self-assembled terplexes for targeted gene delivery with improved transfection. Bioconjug. Chem. 21, 2086-2092 (2010).
30. Mosser, D. M., Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008).
31. McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T., Liu, W. F. Modulation of macrophage phenotype by cell shape. Proc. Natl. Acad. Sci. USA 110, 17253-17258 (2013).
32. Sica, A., Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795 (2012).
33. Simon, J. et al. Systemic macrophage activation in locally-induced experimental arthritis. J. Autoimmun. 17, 127-136 (2001).
34. Haber, E. et al. Route of administration-dependent anti-inflammatory effect of liposomal alendronate. J. Control. Release 148, 226-233 (2010).
35. Dwivedi, P. D., Tripathi, A., Ansari, K. M., Shanker, R., Das, M. Impact of nanoparticles on the immune system. J Biomed Nanotechnol 7, 193-194 (2011).
36. Courties, G. et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J. Am. Coll. Cardiol. 63, 1556-1566 (2014).
37. Hussell, T., Bell, T. J. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81-93 (2014).
38. Gea-Sorli, S., Closa, D. In vitro, but not in vivo, reversibility of peritoneal macrophages activation during experimental acute pancreatitis. BMC Immunol. 10, 42 (2009).